Erratum for Hwu et al., J Clin Oncol 20 (11) 2610-2615.
Erratum for Belanger et al., J Clin Oncol 20 (10) 2567-2574.

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?

ERRATA

The last name of the second author is misspelled. The correct spelling of this author’s last name is Master, not Masters.

The May 15, 2002, article by Belanger et al, entitled "Phase I and Pharmacokinetic Study of Novel l-Nucleoside Analog Troxacitabine Given as a 30-Minute Infusion Every 21 Days" (J Clin Oncol 20:2567-2574, 2002) contained an error.

The email address for the corresponding author is karl.belanger.chum@ssss.gouv.qc.ca (not ".co").

The June 1, 2002, article by Hwu et al, entitled "Temozolomide Plus Thalidomide in Patients With Advanced Melanoma: Results of a Dose-Finding Trial" (J Clin Oncol 20:2610-2615, 2002) contained an error.

Table 4 was incorrectly entitled "Tolerated Doses of Temozolomide." The title of Table 4 should have read "Tolerated Doses of Thalidomide."

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?